AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$CBRS

Lie Sean sold $151.1M of CBRS

Lie Sean (Chief Technology Officer) sold 726,540 shares of Cerebras Systems Inc. (CBRS) at an average of $207.90 ($203.78–$212.64, $151.05M total) across 11 trades over 2026-08-20 to 2026-08-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lie Sean
Published Aug 22, 2026, 12:58 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 22, 2026, 1:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CBRS
Bearish
high confidence
Mentioned
$CBRS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSBearishMed
01

Why it matters

The $151M sale reduces insider ownership and may be interpreted as a negative signal, but could also be a scheduled liquidity event.

02

Market read

Primary insider sale provides fresh material for traders; relevance is moderate to high for short‑term positioning.

03

What to watch

Potential upcoming product launch or financing event that prompted the pre‑arranged sale.

Relevance 7/10Novelty 8/10Timing: filing disclosed today (2026‑08‑22)

Background

SEC Form 4 filing discloses an insider transaction by Cerebras CTO Lie Sean.

Company-level read

Ticker impact

$CBRSBearishHigh confidence
Context

CTO Lie Sean sold 726,540 shares for $151.1M via a 10b5‑1 plan, reducing his stake to 368,926 shares.

Expected impact

Possible short‑term dip of 2‑4% as market digests the sizable sale.

Evidence & confidence

The sale size ($151M) is material for a mid‑cap AI chip maker; insider sales often precede price weakness.

Market effects

Sector

May raise concerns for AI‑hardware sector if other insiders follow suit.

Regional

Limited to US tech equities; no broader regional effect.

Global

Minimal global impact beyond investors tracking Cerebras.

Counterpoint

What could challenge this read

The sale could be a routine 10b5‑1 execution unrelated to fundamentals.

Key entities

  • Company
    Cerebras Systems Inc.

    AI chip maker listed on NASDAQ (CBRS).

  • Executive
    Lie Sean

    Chief Technology Officer of Cerebras.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CBRS insider trading history →

Related articles

$CBRSMed

Why Cerebras Systems Stock Is Plummeting Today

Cerebras Systems (CBRS) shares fell 9.2% after UBS cut its price target by 24% to $250, citing tempered expectations. Despite the reduction, UBS maintains a buy rating, noting potential upside from OpenAI demand and AWS adoption. The stock has also faced criticism from Culper Research, which took a short position. Cerebras is set to report Q3 earnings on Nov. 12.

finance.yahoo.com
$CBRSMed

Why is Cerebras Systems stock sliding today?

Cerebras Systems (CBRS) stock fell 8.3% to a 52-week low of $98.50 after UBS cut its price target to $250 from $330, citing reduced near-term conviction. The decline follows a short-seller report alleging chip degradation and upcoming share unlocks. The stock is down 70% from its high, but analysts maintain Buy ratings.

investing.com
$CBRSHigh

Cerebras Stock Falls as Short Seller Questions Chip Lifespan

Cerebras Systems (CBRS) fell 5.77% after short seller Culper Research alleged its AI chips have a lifespan of 1.5 to 2.5 years and questioned its technology claims. Cerebras has not responded. The drop follows a lockup expiration and reverses part of a previous rally. The stock is far below its 52-week high of $386.34.

finance.yahoo.com
$CBRSHigh

Cerebras Gains 10% on Oracle Cloud Deal as “AI Inference Demands Choice”

Cerebras Systems (CBRS) shares rose 10% and Oracle (ORCL) gained 4% on Oct. 27 after Oracle announced plans to offer Cerebras' AI inference on its cloud starting in 2027. The deal aims to provide customers with more AI chip options. Analysts estimate Cerebras' 2027 revenue at $2.95 billion, though no deal value was disclosed. Cerebras trades at roughly half its average forward price/sales multiple since its IPO.

finance.yahoo.com
$CBRSMed

Why Cerebras Systems Stock Jumped on Tuesday

Cerebras Systems (CBRS) stock rose 10.1% after announcing a partnership with Oracle (ORCL) to offer its AI chip technology to Oracle Cloud Infrastructure customers. The company's Wafer-Scale Engine (WSE) is promoted for its large size and reduced latency. Cerebras reported a 287% year-over-year increase in cloud revenue to $128 million in Q2, but continues to incur losses.

finance.yahoo.com